Physician profile
Michael E Goldis
NPI 1982603247
$1,763.82
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $993 · 2021: $13.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $475.72 | 2019-2020 | |
| Glaxosmithkline, LLC. | $197.23 | 2019-2020 | |
| Astellas Pharma US INC | $128.54 | 2019-2020 | |
| Amarin Pharma, INC. | $119.86 | 2019-2021 | |
| Kyowa Kirin, INC. | $117.54 | 2020 | |
| Philips North America LLC | $106.39 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.21 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $96.16 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $68.32 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $57.07 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $55.13 | 2019 | |
| Collegium Pharmaceutical, INC. | $40.75 | 2020 | |
| Eisai INC. | $40.07 | 2020 | |
| Mannkind Corporation | $28.80 | 2019 | |
| Ferring Pharmaceuticals INC. | $23.17 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.99 | 2020 | |
| Scilex Pharmaceuticals INC. | $14.78 | 2019 | |
| Circassia INC. | $14.61 | 2019 | |
| Neotract INC. | $14.39 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.07 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.80 | 2019 | |
| Biogen, INC. | $12.94 | 2020 | |
| Gilead Sciences, INC. | $12.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Goldis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.